Wallace Advisory Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-830
Closed -$263K – 192
2024
Q4
$263K Buy
830
+6
+0.7% +$1.61K 0.18% 149
2024
Q3
$308K Sell
824
-27
-3% -$9.61K 0.23% 118
2024
Q2
$318K Buy
851
+170
+25% +$57.4K 0.23% 117
2024
Q1
$312K Buy
681
+85
+14% +$32.2K 0.23% 115
2023
Q4
$290K Sell
596
-63
-10% -$31.1K 0.23% 111
2023
Q3
$295K Sell
659
-20
-3% -$9.4K 0.21% 118
2023
Q2
$330K Hold
679
– – 0.25% 107
2023
Q1
$330K Buy
679
+23
+4% +$11.4K 0.25% 107
2022
Q4
$336K Buy
+656
New +$345K 0.27% 105

Other funds holding HUM

Wallace Advisory Group's HUM Position: Q1 2025 in Review

Wallace Advisory Group sold out of Humana (HUM) in Q1 2025, closing a stake of 830 shares — an estimated $263K sold.

Wallace Advisory Group first reported a position in HUM in Q4 2022 and held it in 9 quarters. The position peaked at $336K in Q4 2022. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Wallace Advisory Group reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Wallace Advisory Group sold 830 Humana shares in Q1 2025, an estimated $263K.
  • Wallace Advisory Group first reported a position in Humana in Q4 2022 and held it in 9 quarters.
  • Wallace Advisory Group's Humana position peaked at $336K in Q4 2022.
  • 903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Wallace Advisory Group's 13F filing for Q1 2025, filed 9 Apr 2025.